Thank you, Dr Vander Steichel!

    As Dr. Didier Vander Steichel, our esteemed Medical and Scientific Director of the Foundation against Cancer embarks on a new journey of retirement, we want to express our heartfelt gratitude for his invaluable contributions to our organization.

    Since the inception of our initiative, Dr. Vander Steichel has been an integral part of our team, lending his strategic vision, human capacities, and wealth of experience in cancer care to our mission. His keen understanding of the broader context and acute awareness of sensitivities have played a pivotal role in the success of our endeavors.

    Dr. Vander Steichel’s presence has not only enriched our discussions but also elevated the effectiveness of our board. His unique perspective and fresh insights have been instrumental in guiding us towards greater efficiency in cancer care.

    While we will miss Dr.Vander Steichel´s expertise and camaraderie, we wholeheartedly wish him the very best as he embarks on this new chapter of his life.
    Your legacy will continue to inspire us as we strive to fulfill our mission.

    We welcome Dr Véronique Le Ray, who will replace Dr Vander Steichel for the remainder of his mandate in the board.

    More articles

    Lung cancer screening: worth considering

    All.Can Belgium calls on policy makers to consider a national lung cancer screening program. Such a screening program can save lives, and there is both scientific evidence and public support for such a program.

    Cum Cura: Rare but not devoid of care

    Lina Vissenaeken, principal of a secondary school in East Flanders, has lived with a prosthetic knee for nearly 20 years after being diagnosed with osteosarcoma. “When I'm in pain, I limp, but my students are used to it now,” she says. Together with Cum Cura, a non-profit organization, she advocates…

    Look back: cancer care requires a paradigm shift

    Belgium is an internationally recognized leader in oncological research. Yet, the wave of innovations has not fully addressed cancer patients' needs. Advances in medication, digital technologies, and artificial intelligence necessitate a fresh perspective and a significant shift in mindset among policymakers and stakeholders in the healthcare sector.